Education
About Us
Working with TipRanks
Follow Us
Innocan Pharma Corporation (TSE:INNO)
:INNO
INNO Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.15 - C$0.27
Previous CloseN/A
Volume118.77K
Average Volume (3M)57.64K
Market Cap
C$61.41M
Enterprise ValueC$39.72M
Total Cash (Recent Filing)C$6.37M
Total Debt (Recent Filing)$1.30M
Price to Earnings (P/E)―
Beta0.17
Next Earnings
Sep 01, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding292,420,170
10 Day Avg. Volume14,050
30 Day Avg. Volume57,642
Financial Highlights & Ratios
PEG Ratio-1.05
Price to Book (P/B)9.50
Price to Sales (P/S)0.00
P/FCF Ratio-92.88
Enterprise Value/Market Cap0.65
Enterprise Value/Revenue0.35
Enterprise Value/Gross Profit1.45
Enterprise Value/Ebitda-14.06
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
InnoCan Pharma News
PremiumCompany Announcements
Innocan Pharma Reports Promising Study Results and Corporate Changes
PremiumCompany Announcements
Innocan Pharma’s Synthetic CBD Review to be Presented at PAINWEEK 2025
PremiumCompany Announcements
Innocan Pharma Advances Non-Opioid Pain Management with Synthetic CBD
PremiumCompany Announcements
Innocan Pharma Reports Strong Q1 2025 Results and Advances CBD Technology
PremiumCompany Announcements
Innocan Pharma Secures First Mexican Patent for Cannabis-Based Pain Relief
PremiumCompany Announcements
Innocan Pharma Closes Private Placement to Bolster Operations
PremiumCompany Announcements
Innocan Pharma Expands IP in Asia and Announces Private PlacementPremiumCompany Announcements
Innocan Pharma’s 2024 Revenue Surges Amid Strategic GrowthOptions Prices
Currently, No data available
---
Ownership Overview
5.67% Insiders
―
Mutual Funds
― Other Institutional Investors
94.33% Public Companies and
Individual Investors
INNO FAQ
What was Innocan Pharma Corporation’s price range in the past 12 months?
Innocan Pharma Corporation lowest stock price was C$0.15 and its highest was C$0.27 in the past 12 months.
What is Innocan Pharma Corporation’s market cap?
Innocan Pharma Corporation’s market cap is C$61.41M.
When is Innocan Pharma Corporation’s upcoming earnings report date?
Innocan Pharma Corporation’s upcoming earnings report date is Sep 01, 2025 which is in 43 days.
How were Innocan Pharma Corporation’s earnings last quarter?
Currently, no data Available
Is Innocan Pharma Corporation overvalued?
According to Wall Street analysts Innocan Pharma Corporation’s price is currently Overvalued.
Does Innocan Pharma Corporation pay dividends?
Innocan Pharma Corporation does not currently pay dividends.
What is Innocan Pharma Corporation’s EPS estimate?
Innocan Pharma Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Innocan Pharma Corporation have?
Innocan Pharma Corporation has 292,420,170 shares outstanding.
What happened to Innocan Pharma Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Innocan Pharma Corporation?
Currently, no hedge funds are holding shares in TSE:INNO
Company Description
Innocan Pharma Corporation
InnoCan Pharma (INNO) is a pharmaceutical company focused on developing innovative therapeutic solutions leveraging cannabinoid science. It operates primarily in the biotechnology and pharmaceutical sectors, with a core emphasis on the research and development of novel drug delivery systems and pharmaceutical products. InnoCan Pharma is engaged in creating advanced topical treatments, unique delivery platforms, and therapies that harness the therapeutic potential of cannabinoids to address various medical needs.
Technical Analysis
Mountain Valley MD
―
Medicure
―
Medexus Pharmaceuticals Inc
―
Revive Therapeutics
―
BioNxt Solutions
―